NTA-1

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameNTA-1

Drug Alias Nameanticancer agents (integrin alpha-v/beta-3 inhibitors) (Nuevolution)anticancer agents (Nuevolution)NTA-1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists

TargetsIntegrin alpha-V/beta-3

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesNuevolution AS

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesNuevolution AS

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A